Appendix B: Acronyms
| Acronym | Name |
|---|---|
| ACTG | AIDS Clinical Trials Group |
| AMP | Adolescent Master Protocol |
| ANRS | National Agency for AIDS Research (France) |
| ARROW | AntiRetroviral Research fOr Watoto |
| ATHENA | AIDS Therapy Evaluation in the Netherlands |
| ATLAS | Antiretroviral Therapy as Long-Acting Suppression |
| BAN | Breastfeeding, Antiretrovirals, and Nutrition |
| CHAPAS | Children with HIV in Africa—Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens |
| CHER | Children with HIV Early Antiretroviral Therapy |
| DolPHIN-2 | Dolutegravir in Pregnant HIV Mothers and Their Neonates |
| ECHO | Evidence for Contraceptive Options and HIV Outcomes |
| ENCORE | Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy |
| EPIICAL | Early-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies |
| EPPICC | European Pregnancy and Paediatric Infections Cohort Collaboration |
| FLAIR | First Long-Acting Injectable Regimen |
| HPTN | HIV Prevention Trials Network |
| IeDEA | International Epidemiology Databases to Evaluate AIDS |
| IMPAACT | International Maternal Pediatric Adolescent AIDS Clinical Trials |
| LATTITUDE | Long-Acting Therapy to Improve Treatment Success in Daily LifE |
| MOCHA | More Options for Children and Adolescents |
| NADIA | Nucleosides And Darunavir/Dolutegravir in Africa |
| NEVEREST | Nevirapine Resistance Study |
| ODYSSEY | Once-daily DTG based ART in Young people vS Standard thErapY |
| PACTG | Pediatric AIDS Clinical Trials Group |
| PAINT | Pediatric Study in Adolescents Investigating a New NNRTI TMC278 |
| PENPACT | Trial run in collaboration between PENTA and PACTG/IMPAACT |
| PENTA | Paediatric European Network for Treatment of AIDS |
| PHACS | Pediatric HIV/AIDS Cohort Study |
| PIANO | Paediatric study of Intelence As an NNRTI Option |
| PREDICT | Early Versus Deferred Antiretroviral Therapy for Children Older Than 1 Year Infected with HIV |
| PROMISE | Promoting Maternal and Infant Survival Everywhere Study |
| PROMOTE | PEPFAR PROMise Ongoing Treatment Evaluation |
| SBIRT | Screening, Brief Intervention, and Referral to Treatment |
| SMILE | Strategy for Maintenance of HIV Suppression with Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children |
| START | Strategic Timing of AntiRetroviral Treatment |
| SWORD-1 and SWORD-2 | Regimen Switch to Dolutegravir + Rilpivirine from Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults |
Appendix B: Acronyms
| Acronym | Name |
|---|---|
| ACTG | AIDS Clinical Trials Group |
| AMP | Adolescent Master Protocol |
| ANRS | National Agency for AIDS Research (France) |
| ARROW | AntiRetroviral Research fOr Watoto |
| ATHENA | AIDS Therapy Evaluation in the Netherlands |
| ATLAS | Antiretroviral Therapy as Long-Acting Suppression |
| BAN | Breastfeeding, Antiretrovirals, and Nutrition |
| CHAPAS | Children with HIV in Africa—Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens |
| CHER | Children with HIV Early Antiretroviral Therapy |
| DolPHIN-2 | Dolutegravir in Pregnant HIV Mothers and Their Neonates |
| ECHO | Evidence for Contraceptive Options and HIV Outcomes |
| ENCORE | Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy |
| EPIICAL | Early-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies |
| EPPICC | European Pregnancy and Paediatric Infections Cohort Collaboration |
| FLAIR | First Long-Acting Injectable Regimen |
| HPTN | HIV Prevention Trials Network |
| IeDEA | International Epidemiology Databases to Evaluate AIDS |
| IMPAACT | International Maternal Pediatric Adolescent AIDS Clinical Trials |
| LATTITUDE | Long-Acting Therapy to Improve Treatment Success in Daily LifE |
| MOCHA | More Options for Children and Adolescents |
| NADIA | Nucleosides And Darunavir/Dolutegravir in Africa |
| NEVEREST | Nevirapine Resistance Study |
| ODYSSEY | Once-daily DTG based ART in Young people vS Standard thErapY |
| PACTG | Pediatric AIDS Clinical Trials Group |
| PAINT | Pediatric Study in Adolescents Investigating a New NNRTI TMC278 |
| PENPACT | Trial run in collaboration between PENTA and PACTG/IMPAACT |
| PENTA | Paediatric European Network for Treatment of AIDS |
| PHACS | Pediatric HIV/AIDS Cohort Study |
| PIANO | Paediatric study of Intelence As an NNRTI Option |
| PREDICT | Early Versus Deferred Antiretroviral Therapy for Children Older Than 1 Year Infected with HIV |
| PROMISE | Promoting Maternal and Infant Survival Everywhere Study |
| PROMOTE | PEPFAR PROMise Ongoing Treatment Evaluation |
| SBIRT | Screening, Brief Intervention, and Referral to Treatment |
| SMILE | Strategy for Maintenance of HIV Suppression with Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children |
| START | Strategic Timing of AntiRetroviral Treatment |
| SWORD-1 and SWORD-2 | Regimen Switch to Dolutegravir + Rilpivirine from Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults |
Download Guidelines
-
Section Only PDF (91.66 KB)
-
Full Guideline PDF (6.78 MB)
-
Recommendations Only PDF (226.89 KB)
-
Tables Only PDF (1.04 MB)
-
Drug Tables Only PDF (2.39 MB)